Advertisement
Joe Kaufmann, President and CEO, will be hosting a teleconferencediscussing the earnings results on Friday, October 19, 2007 at 9:00 A.M.Eastern Time.
Advertisement
To participate in the teleconference call, dial 1-651-291-5254. Theteleconference call will also be available for replay starting Friday,October 19, 2007 at 12:30 P.M. Eastern Time through Friday, October 26, 2007at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of886702.
Individuals interested in listening to the teleconference may also do soover the Internet at http://www.kenseynash.com. To listen to the liveteleconference call, please go to the http://www.kenseynash.com website andchoose the Investor Relations page. Please allow 15 minutes prior to thestart of the call to register and download and/or install any necessarysoftware. A replay of the teleconference will be archived on thehttp://www.kenseynash.com website and may be accessed following theteleconference.
About Kensey Nash Corporation. Kensey Nash Corporation is a leadingmedical technology company providing innovative solutions and technologies fora wide range of medical procedures. The Company provides an extensive rangeof products into multiple medical markets, primarily in the endovascular,sports medicine and spine markets. Many of the products are based on theCompany's significant expertise in the design, development, manufacturing andprocessing of absorbable biomaterials, which has led to partnerships tocommercialize technologies. Kensey Nash has also commercialized a series ofinnovative products through its own direct endovascular sales force. TheCompany is known as a pioneer in the field of arterial puncture closure, asthe inventor and developer of the Angio-Seal(TM) Vascular Closure Device,which is licensed to St. Jude Medical, Inc.
SOURCE Kensey Nash Corporation
